Hisar Hospital Intercontinental
Hisar Hospital Intercontinental
Turkey, Istanbul
Mustafa Solak
20 years of experience
Clinic is certified :
Brachytherapy for prostate cancer in Turkey typically costs from AUD $3,512 to AUD $7,726 on average. The final price depends on the radiation dose, the specific technique used, and the hospital location. In Australia, this treatment averages around AUD $25,284, meaning patients can save approximately 78%. Most Turkish oncology centres include specialist consultations and airport transfers in their care packages.
Bookimed Expert Insight: Choosing a Turkish centre with international ties can provide exceptional value for money. Anadolu Medical Center, for instance, maintains an affiliation with Johns Hopkins Hospital from the USA. This ensures treatments follow stringent global oncology standards. Leading Istanbul hospitals like Medipol Mega University Hospital also use advanced tools like Gamma Knife, providing high-precision alternatives if clinical needs change.
| Turkey | Thailand | South Korea | |
| Brachytherapy for prostate cancer | from AUD $3,512 | from AUD $15,451 | from AUD $19,384 |
Dr. Mustafa Solak is a clinical oncologist at Hisar Hospital Intercontinental in Istanbul. He completed a fellowship at the prestigious Hacettepe University Cancer Institute. Dr. Solak previously practiced at The University of Texas MD Anderson Cancer Center. He treats a variety of complex cancers, including lung, breast, and gastrointestinal malignancies.
Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.
Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.
He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.
Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.
Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.
Prostate brachytherapy in Turkey delivers success rates between 85% and 95%. It reaches 98% for early-stage localised cancer. These outcomes match international standards. Ten-year disease control rates exceed 90% in accredited centres. These centres use High-Dose Rate (HDR) and Low-Dose Rate (LDR) techniques.
Bookimed Expert Insight: Turkish oncology centres often offer HDR brachytherapy as a temporary implant. This can be safer for patients with urinary issues. Data shows that combined approaches at major hubs like Medipol Mega often result in lower recurrence than surgery. This is for intermediate-risk cases.
Patient Consensus: Success rates for localised cancer are excellent in Turkey. Many reports mention long-term control and low PSA levels. Patients appreciate the lower risk of incontinence compared to traditional surgery.
Leading Turkish oncologists hold prestigious international credentials for prostate brachytherapy. Many specialists complete fellowships at top-tier Western institutions like the University of Texas MD Anderson Cancer Center. They maintain active memberships in global bodies such as the European Society for Therapeutic Radiology and Oncology (ESTRO).
Bookimed Expert Insight: Turkish oncology centres like Anadolu Medical Center bridge the gap between local care and global standards. They do so through direct affiliations with US institutions. This partnership means treatment protocols for brachytherapy and similar therapies are aligned. They match those used in the world’s top cancer hospitals.
Patient Consensus: Patients in Turkey suggest verifying each doctor’s specific training pathway and hospital accreditation before booking. Experience shows that verifying JCI certification and Johns Hopkins affiliations provides the most confidence. This is especially important for prostate cancer treatments.
JCI-accredited oncology centres in Turkey primarily offer Low-Dose Rate (LDR) and High-Dose Rate (HDR) brachytherapy. These treatments use internal radiation to target localised prostate cancer. Leading facilities in Istanbul and Ankara use image guidance for precise placement while sparing healthy tissue.
Bookimed Expert Insight: While LDR seeds are traditional, major Turkish hubs like Anadolu Medical Center and Medipol Mega now favour HDR brachytherapy. HDR allows for more precise dose adjustments after the tubes are placed. This often results in better protection for the bladder and rectum compared to permanent seeds.
Patient Consensus: Patients in Turkey find that HDR is often completed in a single day under anaesthesia. The internal approach reduces typical radiation side effects, helping them return to light activities quickly.
Turkey hosts several Joint Commission International (JCI) accredited hospitals specialising in prostate brachytherapy. Leading centres like Anadolu Medical Center and Memorial Bahçelievler Hospital use precision technologies. These include 3T MRI and Elekta Versa HD radiotherapy. They deliver internal radiation that targets tumours while sparing healthy tissue.
Bookimed Expert Insight: Anadolu Medical Center holds both JCI and OECI accreditations. This rare combination signals adherence to strict European cancer institute standards. Their affiliation with Johns Hopkins gives Australian patients access to American-model oncology protocols at Turkish price points. These often start from $2,500.
Patient Consensus: Patients recommend focusing on large Istanbul systems like Memorial or Acıbadem. These have dedicated international departments. They suggest confirming the specific oncology specialist and asking for a written treatment plan in Turkey.